🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07685587
Recruiting Not applicable

COMPARISON OF FANS VS CONVENTIONAL URETERAL ACCESS SHEATH in RIRS on POSTOPERATIVE ACUTE KIDNEY INJURY

NCT07685587 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-05-04
Last updated
2026-07-06

Condition(s) studied

Urolithiasis

Investigational drug(s) / intervention(s)

flexible and navigable ureteral access sheathconventional ureteral access sheath

flexible and navigable ureteral access sheath: Patients of RIRS operated with flexible and navigable ureteral access sheath

conventional ureteral access sheath: Patients of RIRS operated with conventional ureteral access sheath

Study summary

Kidney stone disease is a common condition, and retrograde intrarenal surgery (RIRS) is a minimally invasive procedure frequently used to remove kidney stones. During RIRS, pressure inside the kidney can increase, which may contribute to temporary kidney injury. New aspiration-enabled access sheath systems have been developed to better control this pressure by continuously removing irrigation fluid during surgery. This study will compare aspiration and conventional access sheath systems to determine whether improved pressure control reduces early kidney injury. Blood and urine biomarkers (IL-18 and L-FABP), which can detect kidney damage earlier than standard kidney function tests, will be measured before and after surgery. The results may help identify surgical techniques that better protect kidney function and improve the safety of kidney stone treatment for patients.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Being 18 years of age or older * Having a planned RIRS operation * Providing written informed consent Exclusion Criteria: * Patients who do not give consent * Patients who will undergo combined surgery * Patients who have previously undergone endoscopic stone surgery * Being under 18 years of age * Patients with chronic kidney failure * Patients with kidney malformations * Patients with a solitary kidney * Patients using nephrotoxic drugs

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Tekirdag Namık Kemal University Tekirdağ Turkey (Türkiye) Recruiting

More Namik Kemal University trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07685587 on ClinicalTrials.gov ↗ ← All trials in Turkey